Banbury Center of Cold Spring Harbor Meeting on Microbiology, Immunology and Toxicology of Autism and Other Neurodevelopmental Disorders February 11–14, 2001

Total Page：16

File Type：pdf, Size：1020Kb

Banbury Center of Cold Spring Harbor Meeting on Microbiology, Immunology and Toxicology of Autism and Other Neurodevelopmental Disorders February 11–14, 2001

Molecular Psychiatry (2002) 7,S1 2002 Nature Publishing Group All rights reserved 1359-4184/02 $25.00 www.nature.com/mp INTRODUCTION TO AUTISM Banbury Center of Cold Spring Harbor meeting on microbiology, immunology and toxicology of autism and other neurodevelopmental disorders February 11–14, 2001 Molecular Psychiatry (2002) 7, S1. doi:10.1038/ government and autism foundations could pursue con- sj.mp.4001160 sensus regarding what we know and what we need to know. What emerged was a patchwork of intriguing observations and recognition that autism spectrum dis- In autumn 1999 Jan Witkowski generously agreed to orders impact several organ systems and are likely to host a meeting at the Banbury Center of Cold Spring be multifactorial. Banbury Meetings are closed and Harbor to address concerns that the frequency of typically do not result in publications; however, autism was increasing in Europe and North America, autism research is only beginning to crystallize as a and that vaccines containing attenuated measles virus ﬁeld; thus, participants were eager to share their data or thimerosal (used as a preservative in multidose vac- and insights with a larger audience. We hope that this cine preparations) might be implicated in pathogenesis supplement will sharpen focus on autism spectrum of autism spectrum disorders. With support from Co- disorders and attract new investigators to this frontier. Organizers, Mady Hornig (University of California, Although the meeting was convened 11–14 February Irvine) and David Amaral (MIND Institute of University 2001, manuscripts were submitted in the winter of of California, Davis), the extraordinary staff at Banbury 2001–2002. Manuscripts are presented without editing Center, and input from participants, this meeting was for content. A generous gift from Judith P Sulzberger expanded to review the status of research and treat- to the Center for Developmental Neuroscience of ment of autism spectrum disorders. The MIND Institute Columbia University has allowed us to produce this of UC Davis, Cure Autism Now Foundation, and the supplement. National Alliance for Autism Research provided ﬁn- ancial support. The Banbury Center and crisp weather WI Lipkin of Long Island in February provided an intimacy New York, New York wherein investigators and representatives from academia, February 2002 Correspondence: WI Lipkin, Center for Immunopathogenesis and Infectious Diseases, Columbia University, 722W 168th Street, New York, NY 10032, USA. Email: [email protected].

Copy Link

Recommended publications

May 9-12 Rotterdam Netherlands
2018 ANNUAL MEETING MAY 9-12 ROTTERDAM NETHERLANDS PROGRAM BOOK www.autism-insar.org INSAR 2018 Sponsors We thank the following organizations for their generous support of the INSAR Annual Meeting. Platinum Sponsor Level Gold Sponsor Level Silver Sponsor Level Autism Science Foundation Hilibrand Foundation Nancy Lurie Marks Family Foundation TABLE OF CONTENTS Sponsorship .................................Inside Front Cover TABLE OF CONTENTS Special Interest Groups Schedule .......................... 6 Speaker Ready Room ............................................ 6 De Doelen Floor Plans ........................................ 7-9 Meeting Information Schedule-At-A-Glance .................................... 10-12 In-Conjunction Events .................................... 13-14 Keynote Speakers .............................................. 15 Awardees ..................................................... 16-19 INSAR MISSION Acknowledgments .......................................... 20-21 STATEMENT To promote the highest quality INSAR Summer Institute .................................... 22 research in order to improve the Abstract Author Index ...................................... 134 lives of people affected by autism. General Information .......................................... 208 Exhibitors ....................................................... 210 Strategic Initiatives Setting the Bar: Increase the quality, AM diversity and relevance of research promoted through annual meetings, journal, Keynote Address ...............................................
[Show full text]
Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children
ORIGINAL CONTRIBUTION Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children ˚ ´ Pal Suren, MD, MPH Importance Prenatal folic acid supplements reduce the risk of neural tube defects Christine Roth, MSc in children, but it has not been determined whether they protect against other neu- Michaeline Bresnahan, PhD rodevelopmental disorders. Margaretha Haugen, PhD Objective To examine the association between maternal use of prenatal folic acid supplements and subsequent risk of autism spectrum disorders (ASDs) (autistic disor- Mady Hornig, MD der, Asperger syndrome, pervasive developmental disorder–not otherwise specified Deborah Hirtz, MD [PDD-NOS]) in children. Kari Kveim Lie, MD Design, Setting, and Patients The study sample of 85 176 children was derived from the population-based, prospective Norwegian Mother and Child Cohort Study W. Ian Lipkin, MD (MoBa). The children were born in 2002-2008; by the end of follow-up on March 31, Per Magnus, MD, PhD 2012, the age range was 3.3 through 10.2 years (mean, 6.4 years). The exposure of Ted Reichborn-Kjennerud, MD, PhD primary interest was use of folic acid from 4 weeks before to 8 weeks after the start of pregnancy, defined as the first day of the last menstrual period before conception. Synnve Schjølberg, MSc Relative risks of ASDs were estimated by odds ratios (ORs) with 95% CIs in a logistic George Davey Smith, MD, DSc regression analysis. Analyses were adjusted for maternal education level, year of birth, and parity. Anne-Siri Øyen, PhD Main Outcome Measure Specialist-confirmed diagnosis of ASDs. Ezra Susser, MD, DrPH Results At the end of follow-up, 270 children in the study sample had been diag- Camilla Stoltenberg, MD, PhD nosed with ASDs: 114 with autistic disorder, 56 with Asperger syndrome, and 100 with PDD-NOS.
[Show full text]
Lower Autism Risk with Folic Acid Supplements in Pregnancy 12 February 2013
Lower autism risk with folic acid supplements in pregnancy 12 February 2013 Women who took folic acid supplements in early of folic acid supplements in the mother during pregnancy almost halved the risk of having a child pregnancy and a reduced risk of childhood autism. with autism. Beginning to take folic acid supplements later in pregnancy did not reduce the "The study does not prove that folic acid risk. This is shown in new findings from the ABC supplements can prevent childhood autism. Study and Norwegian Mother and Child Cohort However, the findings are so apparent that they Study published in the Journal of The American constitute a good argument to further examine Medical Association (JAMA). possible causal mechanisms. It should also be ascertained whether folic acid is associated with a Women who took folic acid supplements from four reduced risk of other brain disorders in children," weeks before conception to eight weeks into says Surén. pregnancy had a 40 per cent lower risk of giving birth to children with childhood autism (classic Emphasises the importance of folic acid autism). Use of folic acid supplements midway supplements through pregnancy (week 22) had no effect. The results support the Norwegian Directorate of The findings only apply to a lower risk of childhood Health's recommendations for folic acid autism, the most severe form of autism. The supplements during pregnancy and emphasise the results show no reduction in the risk of atypical or importance of starting early—preferably before unspecific autism. The study also investigated the conception. prevalence of Asperger syndrome, but the number of examined children was too low to give a reliable Method result.
[Show full text]
An Enlightening Conversation on Autism « Dana Foundation
An Enlightening Conversation on Autism « Dana Foundation https://danablog.org/2016/02/10/an-enlightening-conversation-o... An Enlightening Conversation on Autism FEBRUARY 10, 2016 An hour before a program titled “The Spectrum” began, featured participant David Amaral, Ph.D., complained that in the weeks leading up to the event, he had had trouble getting his hands on Snow Cake, a 2007 film in which Sigourney Weaver plays a high-functioning autistic woman. “I tried Netflix, Amazon Prime, and Hulu, and couldn’t find it anywhere,” said Amaral. “But I was eventually able to find the DVD on Amazon—and liked it very much.” That’s high praise coming from one of the nation’s foremost researchers on autism. Amaral, UC Davis Distinguished Professor of Psychiatry and Neuroscience and the Beneto Foundation chair, and founding research director of the M.I.N.D. Institute, and Weaver, an acclaimed actress, film producer, and noted environmentalist, discussed autism to a sold-out audience at the Rubin Museum of Art in Manhattan. Lyn Hughes Photography, courtesy of the Rubin Museum of Art. The program—the second in an annual Brainwave series that runs through April—opened with a clip from Snow Cake [here’s a short clip via YouTube]. Despite a review in the New York Times that called Weaver’s performance “convincingly precise,” few in the audience had seen or heard of the film. Brain- centric films, even when they are lauded for extraordinary performances (Concussion with Will Smith and Still Alice with Julianne Moore come to mind), rarely live up to box office expectations.
[Show full text]
Message from David Amaral, Scientific Director of Autism Brainnet New Technique Provides Deeper View of Brain Development
December 9, 2020 Message from David Amaral, Scientific Director of Autism BrainNet What a year! Most people would agree that it has been a particularly difficult year with all of the turmoil in our daily lives, in our politics, and the many injustices in our society. I’m writing this over the Thanksgiving weekend and I’m sure many are wondering whether there is anything in 2020 to be thankful for. My answer is a resounding Yes. Read more SCIENCE New technique provides deeper view of brain development Knowing how and when different brain cell types emerge during brain development may help us understand how the brain develops and identify changes that contribute to neurodevelopmental conditions. A new study applied a novel technique to postmortem human brain tissue to provide insights into brain development. Read more about the study Researchers uncover a new way that genes are regulated in the autism brain Hundreds of genes have been linked to autism, but these genes explain only a small portion of cases. A recent study explored the function of circular RNAs, and their effect on gene activity, in the brain of people who have autism. Read more about the study MEET OUR TEAM A conversation with Alicja Omanska, tissue coordinator of Autism BrainNet Sacramento node We recently spoke with Alicja Omanska, tissue coordinator for Autism BrainNet at the UC Davis MIND Institute in Sacramento, CA, to learn more about her research, her role with Autism BrainNet and the importance of advancing autism research. Read the interview NEW COLLABORATIONS Autism BrainNet welcomes the Prader-Willi Syndrome Association and the Families SCN2a Foundation, our newest family group partners.
[Show full text]
Environmental Health Issue
FIFTH EDITION 2006, Volume 45 R5 Environmental Health and Autism In thIs Issue: Time To GeT a Grip By martha r. Herbert, m.D., ph.D. Beyond Behavior—Biomedical Diagnoses in Autism spectrum Disorders By Margaret L. Bauman, M.D. transforming the Public Debate on neurotoxicants By Elise Miller, M.Ed. ADVERTISEMENT ADVERTISEMENT Autism does not have to be a life sentence You’re not about to give up on your child. Neither Are We. Since , the Autism Treatment Center of America™ has provided innovative training programs for parents and professionals caringifor children challenged by Autism Spectrum Disorders and related developmental diﬃculties. • Practical Tools • Powerful Results • Limitless Hope c Help your child improve in all areas of over p learning, development, communication and hoto skill acquisition. : © W I Join us for our internationally-acclaimed ll T ERR Son-Rise Program® Start-Up, a y comprehensive weeklong training program for parents and professionals. We don’t put limits on the possibilities for your child. Free 25-Minute Initial Call 877-766-7473 We’ll give you the keys to unlock their world. HOME OF THE SON-RISE PROGRAM® SINCE 1983 South Undermountain Road Sheﬃeld, MA - USA Telephone: -- • E-mail: [email protected] www.autismtreatment.com Copyright © 2006 by The Option Institute & Fellowship. All rights reserved. 02.06-6 CONTENTS December 2006 page 18 SpOTlIGHT Time to Get A Grip By marTHa r. HerBerT, m.D., pH.D. Does an environmental role in autism make sense? How do we decide? And if environment is involved in autism, what do we do about it? These are challenging questions.
[Show full text]
Sensitivity and Specificity of Early Screening for Autism
BJPsych Open (2019) 5, e41, 1–8. doi: 10.1192/bjo.2019.34 Sensitivity and specificity of early screening for autism Pål Surén, Alexandra Saasen-Havdahl, Michaeline Bresnahan, Deborah Hirtz, Mady Hornig, Catherine Lord, Ted Reichborn-Kjennerud, Synnve Schjølberg, Anne-Siri Øyen, Per Magnus, Ezra Susser, W. Ian Lipkin and Camilla Stoltenberg Background (95% CI 58–79) for ASD without phrase speech and 34% (95% CI – Early identification and diagnosis is beneficial for children with 29 40) for ASD with phrase speech. Specificity was then reduced – autism spectrum disorder (ASD). Universal early screening is to 89% (95% CI 89 90). recommended by many experts, but disputed because evidence is limited, and sensitivity and specificity in general populations Conclusions are largely unknown. Early ASD screening with a parent checklist had low sensitivity. It identified mainly individuals with ASD with significant develop- Aims mental delay and captured very few children with ASD with To estimate the sensitivity and specificity of early population- cognitive skills in the normal range. Increasing sensitivity was not based screening for ASDs. possible without severely compromising specificity. Method Declaration of interest The study was based on the Norwegian Mother and Child Cohort C.L. receives royalty for the Social Communication Study. The 36-month cohort questionnaire included the Social Questionnaire, which she has co-authored. Communication Questionnaire (SCQ), a 40-item screening instrument for ASD. Keywords Results Autistic spectrum disorders; developmental disorders; A total of 58 520 mothers (58%) responded to the questionnaire. epidemiology. By the end of follow-up on 31 December 2015, 385 (0.7%) indi- viduals with ASD had been identified among the responders’ Copyright and usage children.
[Show full text]
Prenatal Exposure to Antipsychotic Medication Does Not Increase Odds of Autism, ADHD
Spectrum | Autism Research News https://www.spectrumnews.org NEWS Prenatal exposure to antipsychotic medication does not increase odds of autism, ADHD BY PETER HESS 20 AUGUST 2021 Listen to this story: Children born to mothers who take antipsychotic medications during pregnancy do not have elevated odds of autism or attention deficit hyperactivity disorder (ADHD), nor are they more likely to be born preterm or underweight, according to a study released this past Monday in JAMA Internal Medicine. Some women with schizophrenia, Tourette syndrome or bipolar disorder take antipsychotic drugs, such as aripiprazole, haloperidol or risperidone. Clinicians have long debated whether women should discontinue these medications during pregnancy out of concern for the drugs’ effects on the developing fetus. But children born to mothers who take antipsychotics during pregnancy and to those who do not take them have similar outcomes, the new work shows. “Our findings do not support a recommendation for women to discontinue their regular antipsychotic treatment during pregnancy,” says senior investigator Kenneth Man, research fellow at the University College London School of Pharmacy in the United Kingdom. Prescribing antipsychotics during pregnancy can help prevent potentially dangerous psychotic episodes and ensure that an expectant mother can take care of herself, says Mady Hornig, associate professor of epidemiology at Columbia University, who was not involved in the study. “We certainly don’t want to be cavalier about the use of any medication during pregnancy, but one 1 / 2 Spectrum | Autism Research News https://www.spectrumnews.org also wants to balance out the implications of not treating.” Any apparent effects of antipsychotics on a developing fetus are likely due to the condition being treated, rather than the treatment, the study shows.
[Show full text]
IBIS Biological Psychiatry Paper.2.Pub
Researchers at the Carolina Institute for Developmental Disabilities Link Brain Changes in Infancy to Autism A national research network led by UNC School of Medicine’s Joseph Piven, M.D., found that many toddlers diagnosed with autism at 2 years of age had a substantially greater amount of brain fluid at 6 and 12 months of age, before diagnosis is possible. CHAPEL HILL, NC – “The cerebral spinal fluid Until the last (CSF) is easy to see on standard MRIs and decade, the points to a potential biomarker of autism before scientific and symptoms appear years later,” said Piven, co- medical communities senior author of the study, the Thomas E. Cas- viewed CSF telloe Distinguished Professor of Psychiatry, and as merely a director of the Carolina Institute for Developmen- protective tal Disabilities (CIDD). “We also think this finding layer of fluid provides a potential therapeutic target for a sub- between the set of people with autism.” brain and skull, not necessarily important for proper brain de- The findings, published in Biological Psychiatry, velopment and behavioral health. But scientists then point to faulty CSF flow as one of the possible discovered that CSF acted as a crucial filtration sys- causes of autism for a large subset of people. tem for byproducts of brain metabolism. “We know that CSF is very important for brain Every day, brain cells communicate with each other. health, and our data suggest that in this large These communications cause brain cells to continu- subset of kids, the fluid is not flowing properly,” ously secrete byproducts, such as inflammatory pro- said Mark Shen, Ph.D., CIDD postdoctoral fellow teins that must be filtered out several times a day.
[Show full text]
Read the Full Survey Report
Evaluating a Proposed Name to Replace ‘ME/CFS’: A Community Survey Project Conducted by Lisa Petrison, Ph.D. Published by Paradigm Change (March 2015) Copyright 2015 www.paradigmchange.me 2 Table of Contents Executive Summary ...................................................................................................................................... 5 Part 1 – Results Overview .......................................................................................................................... 13 Part 2 - Implications ................................................................................................................................... 29 Part 3 – Survey Questions .......................................................................................................................... 49 Part 4 – Main Survey Results ..................................................................................................................... 66 Part 5 – ME vs. Non-ME Results ............................................................................................................... 110 Part 6 – US ME vs. Non-ME Results ......................................................................................................... 127 Part 7 – Related Illnesses Results ............................................................................................................ 161 Part 8 – US vs. Non-US Results ................................................................................................................. 181
[Show full text]
IMFAR 2004 Program Book
2004 PROGRAM Friday & Saturday May 7 – 8, 2004 The Hyatt Hotel Sacramento, California 1 I M F A R Acknowledgements Board Members Program Committee President David Amaral Linda Daly Marian Sigman, PhD University of California, Davis University of California, Los MIND Institute Petrus de Vries Angeles Cambridge University Anthony Bailey Oxford University Glen Dunlap Vice President Sally Rogers, PhD University of South Florida Grace Baranek University of California, Davis University of North Carolina at MIND Institute Chapel Hill Deborah Fein University of Connecticut Treasurer Simon Baron-Cohen Edwin Cook, MD Cambridge University Eric Fombonne University of Chicago McGill University Marlene Behrmann Secretary Carnegie Mellon University Christopher Gillberg Diane Chugani, PhD Hill Goldsmith Wayne State University Susan Bookheimer University of California, Los University of Wisconsin Program Chair Angeles Robin Hansen Nancy Minshew, MD University of California, Davis University of Pittsburgh Medical Dermot Bowler City University Center Sandra Harris Rutgers University Membership Chair Marie Bristol-Power Robert Schultz, PhD Robert Hendren Yale University Jacob Burak University of California, Davis McGill University Nominations Chair Susan Hyman Joseph Piven, MD Tony Charman University of Rochester University of North Carolina University College London Chapel Hill Bob Joseph Diane Chugani Boston University School of Publications Chair Wayne State University/ Medicine David Amaral, PhD Children’s Hospital of Michigan University of California,
[Show full text]
May 9-12 Rotterdam Netherlands
2018 ANNUAL MEETING MAY 9-12 ROTTERDAM NETHERLANDS PROGRAM BOOK www.autism-insar.org INSAR 2018 Sponsors We thank the following organizations for their generous support of the INSAR Annual Meeting. Platinum Sponsor Level Gold Sponsor Level Silver Sponsor Level Autism Science Foundation Hilibrand Foundation Nancy Lurie Marks Family Foundation TABLE OF CONTENTS Sponsorship .................................Inside Front Cover TABLE OF CONTENTS Special Interest Groups Schedule .......................... 6 Speaker Ready Room ............................................ 6 De Doelen Floor Plans ........................................ 7-9 Meeting Information Schedule-At-A-Glance .................................... 10-12 In-Conjunction Events .................................... 13-14 Keynote Speakers .............................................. 15 Awardees ..................................................... 16-19 INSAR MISSION Acknowledgments .......................................... 20-21 STATEMENT To promote the highest quality INSAR Summer Institute .................................... 22 research in order to improve the Abstract Author Index ...................................... 134 lives of people affected by autism. General Information .......................................... 208 Exhibitors ....................................................... 210 Strategic Initiatives Setting the Bar: Increase the quality, AM diversity and relevance of research promoted through annual meetings, journal, Keynote Address ...............................................
[Show full text]